Posted by Michael Wonder on 18 Sep 2018
EMA publishes agenda for CHMP 17-20 September meeting
17 September 2018 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Brigatinib
- Paclitaxel
- Buprenorphine
- Doravirine
- Doravirine with lamivudine and tenofovir disoproxil fumarate
- Galcanazumab
- Pegfilgrastim
- Damoctocog alfa pegol
- Voretigene neparvovec
- Mogamulizumab
- Meropenem with vaborbactam
